70 Percent Say They Would Conduct At-Home Test for Suspected COVID-19
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

WEDNESDAY, July 2, 2025 -- Seventy percent of U.S. adults would conduct a home test for suspected COVID-19, according to a study published online June 30 in JAMA Network Open.
Kimberly A. Fisher, M.D., from UMass Chan Medical School in Worchester, and colleagues examined current intent to test for COVID-19 in a cross-sectional online national survey conducted among U.S. adults between Oct. 31 and Nov. 7, 2024.
A total of 2,009 individuals responded to the question on COVID-19 self-testing. The researchers found that 70.0 percent of respondents said they would test if they suspected COVID-19. In a multivariate analysis, a higher likelihood of testing was seen for those older than 60 years; identifying as non-Hispanic Black, Hispanic, or other or multiple race, non-Hispanic; reporting other than excellent health; having higher trust in the health care system; strongly agreeing that they depend on numbers to make decisions about health; and having previously completed a COVID-19 home test. Reasons for not or possibly not testing included not seeing a reason to test (53.6 percent), believing it would not be helpful to know if they were COVID-19 positive (30.1 percent), not trusting test results (20.7 percent), preferring not to know (9.1 percent), not knowing where to get a test (5.8 percent), and being unable to afford a test (4.9 percent).
"Test hesitancy may delay oral antiviral initiation and could result in missed opportunities to limit transmission," the authors write. "Efforts are needed to increase awareness of the value of testing."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-03 12:00
Read more

- KalVista Pharmaceuticals Announces FDA Will Not Meet PDUFA Goal Date for Sebetralstat NDA for Hereditary Angioedema Due to FDA Resource Constraints
- Telehealth Intervention Beneficial for Seniors With Metastatic Cancer
- 2023 Unintentional Fall Death Rate Was 69.9/100,000 in Those Aged 65 and Older
- New Blood Test Promises Pain-Free Diagnosis Of Celiac Disease
- FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
- Novo Nordisk's Mim8 Prophylaxis Treatment Shown to be Well-Tolerated When Switching from Emicizumab in People with Hemophilia A in New Phase 3 Data
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions